Ninety-day outcomes after percutaneous cholecystostomy bridging vs. early laparoscopic cholecystectomy in older adults with acute calculous cholecystitis meeting study-specific high-risk criteria: a propensity score-matched cohort study
Year: 2026
Type: article
Study design: Observational Study
Abstract: Background The optimal initial management of acute calculous cholecystitis in older adults with high-risk features remains uncertain, particularly when percutaneous cholecystostomy (PC) is used as a bridge rather than definitive treatment. We compared 90-day clinical outcomes and healthcare utilisation after PC bridging vs. early laparoscopic cholecystectomy (LC) in older adults meeting study-specific high-risk criteria. Methods In this single-center retrospective cohort study, consecutive adults aged ≥65 years with acute calculous cholecystitis were screened over a 4-year period. High-risk status was defined using a study-specific composite of ASA-PS III–IV, CCI ≥6, TG18 grade II–III disease, age ≥80 years, or albumin <35 g/L. Patients initially managed with PC bridging were compared with those undergoing early LC during the index admission. The primary outcome was a 90-day composite adverse outcome comprising Clavien–Dindo grade ≥ III complication, unplanned readmission, biliary-related reintervention, recurrent biliary event, or all-cause death. Propensity-score matching was used for the primary comparison, with exploratory subgroup analyses and sensitivity analyses used to assess heterogeneity and robustness. Results Among 562 screened patients, 448 adults aged ≥65 years who met the study-specific high-risk criteria were included; 162 were managed with PC bridging and 286 underwent early LC. Propensity-score matching yielded 145 pairs. In the matched cohort, PC bridging was associated with a higher 90-day composite adverse-outcome rate (35.9% vs. 24.8%; risk difference, 11.1%; OR, 1.70; 95% CI, 1.00–2.90; P = 0.049), driven mainly by higher unplanned readmission (20.0% vs. 11.0%; OR, 2.02; 95% CI, 1.04–3.94; P = 0.037), biliary-related reintervention (14.5% vs. 5.5%; OR, 2.90; 95% CI, 1.24–6.80; P = 0.011), and recurrent biliary events (12.4% vs. 4.1%; OR, 3.28; 95% CI, 1.27–8.49; P = 0.010). No statistically significant between-group differences were demonstrated for major complications (15.2% vs. 11.0%; P = 0.298), ICU admission (12.4% vs. 9.0%; P = 0.340), or 90-day mortality (4.8% vs. 2.8%; P = 0.361). PC bridging was also associated with longer cumulative hospital stay (median, 13 vs. 9 days; P < 0.001) and higher cumulative healthcare cost (median, 46.8 vs. 38.2 × 10 3 CNY; P = 0.008). The direction of the primary association was consistent across sensitivity analyses, although confidence intervals crossed the null in several analyses, including repeat matching with the stricter high-risk definition (OR, 1.58; 95% CI, 0.93–2.70; P = 0.091). Conclusions Among older adults meeting the study-specific high-risk criteria, PC bridging was associated with more readmissions, biliary-related reinterventions, recurrent biliary events, and greater 90-day healthcare utilisation after propensity-score matching, while no statistically significant difference was demonstrated in major complications or mortality. These findings are consistent with more favourable short-term outcomes after early LC in selected patients considered able to tolerate surgery, but residual confounding and incomplete statistical robustness warrant cautious interpretation.
Source: Frontiers in Surgery
Authors: Chen Zhang(Conceptualization, Data curation, Formal analysis, Investigation, Writing – original draft), Zhen Chen(Data curation, Formal analysis, Investigation, Writing – review & editing), Boyu Chen(Data curation, Investigation, Writing – review & editing), Feifei Ji(Data curation, Investigation, Writing – review & editing), Yueguang Li(Conceptualization, Methodology, Supervision, Writing – review & editing)
Language: English
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7233814071
